Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Hua Medicine Files for Hong Kong IPO -- Rumors Predict a $200 Million Debut
Ascletis, a Pre-Revenue China Biopharma, Files for Hong Kong IPO
WuXi AppTec IPOs in Shanghai Exchange
Hong Kong Aims to be IPO Venue of Choice for Young China Life Science Companies
Ping An Healthcare and Technology Plans $1 Billion HK IPO for May
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China